GT BIOPHARMA, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
GT BIOPHARMA, INC. (GTBP) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-03-01
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $0.00.
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00.
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00.
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00.
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $0.00.
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- GT BIOPHARMA, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $28.00K, a 92.39% decline from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 | ||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2017-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 | ||
| 2016-09-30 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 10-Q/A · filed 2018-02-28 | |||
| 2016-06-30 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 10-Q/A · filed 2018-02-28 | ||||
| 2015-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 10-K/A · filed 2018-02-28 | ||
| 2015-09-30 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2015-06-30 | $0.00 10-Q/A · filed 2018-02-28 | $20.00K 10-Q · filed 2015-08-14 | $0.00 10-Q/A · filed 2018-02-28 | $27.00K 10-Q · filed 2015-08-14 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $3.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-14 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $3.00K derived: sum of 3 quarters · filed 2018-02-28 | $28.00K derived: sum of 4 quarters · filed 2018-02-28 | ||
| 2014-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $3.00K derived: sum of 2 quarters · filed 2018-02-28 | $28.00K derived: sum of 3 quarters · filed 2018-02-28 | $28.00K 10-K/A · filed 2018-02-28 | ||
| 2014-09-30 | $3.00K 10-Q · filed 2015-11-13 | $28.00K derived: sum of 2 quarters · filed 2015-11-13 | $28.00K 10-Q · filed 2015-11-13 | $69.00K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $25.00K 10-Q · filed 2015-08-14 | $25.00K 10-Q · filed 2015-08-14 | $66.00K derived: sum of 3 quarters · filed 2015-08-14 | $249.00K derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $41.00K derived: sum of 2 quarters · filed 2015-05-14 | $224.00K derived: sum of 3 quarters · filed 2015-05-14 | $280.00K derived: sum of 4 quarters · filed 2015-05-14 | ||
| 2013-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $224.00K derived: sum of 2 quarters · filed 2015-03-31 | $280.00K derived: sum of 3 quarters · filed 2015-03-31 | $368.00K 10-K · filed 2015-03-31 | ||
| 2013-09-30 | $183.00K 10-Q · filed 2014-12-17 | $239.00K derived: sum of 2 quarters · filed 2015-01-08 | $327.00K 10-Q · filed 2015-01-08 | $546.00K derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2013-06-30 | $56.00K 10-Q · filed 2015-01-08 | $144.00K 10-Q · filed 2015-01-08 | $363.00K derived: sum of 3 quarters · filed 2015-01-08 | $483.00K derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2013-03-31 | $88.00K 10-Q · filed 2015-01-08 | $307.00K derived: sum of 2 quarters · filed 2015-01-08 | $427.00K derived: sum of 3 quarters · filed 2015-01-08 | $428.00K derived: sum of 4 quarters · filed 2015-01-08 | ||
| 2012-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | $339.00K derived: sum of 2 quarters · filed 2015-01-08 | $340.00K derived: sum of 3 quarters · filed 2015-01-08 | $342.00K 10-K · filed 2015-01-08 | ||
| 2012-09-30 | $120.00K 10-Q · filed 2014-12-17 | $121.00K derived: sum of 2 quarters · filed 2014-12-17 | $123.00K 10-Q · filed 2014-12-17 | $125.00K derived: sum of 4 quarters · filed 2014-12-17 | ||
| 2012-06-30 | $1.00K 10-Q · filed 2014-12-12 | $2.00K 10-Q · filed 2014-12-12 | $5.00K derived: sum of 3 quarters · filed 2014-12-12 | $7.00K derived: sum of 4 quarters · filed 2014-12-12 | ||
| 2012-03-31 | $1.00K 10-Q · filed 2014-12-10 | $4.00K derived: sum of 2 quarters · filed 2014-12-10 | $6.00K derived: sum of 3 quarters · filed 2014-12-10 | $7.00K derived: sum of 4 quarters · filed 2014-12-10 | ||
| 2011-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $5.00K derived: sum of 2 quarters · filed 2014-11-18 | $6.00K derived: sum of 3 quarters · filed 2014-11-18 | $26.00K 10-K · filed 2014-11-18 | ||
| 2011-09-30 | $2.00K 10-Q · filed 2012-11-21 | $3.00K derived: sum of 2 quarters · filed 2012-11-21 | $23.00K 10-Q · filed 2012-11-21 | $34.00K derived: sum of 4 quarters · filed 2012-11-21 | ||
| 2011-06-30 | $1.00K 10-Q/A · filed 2012-09-13 | $21.00K 10-Q/A · filed 2012-09-13 | $32.00K derived: sum of 3 quarters · filed 2012-09-13 | $32.00K derived: sum of 4 quarters · filed 2012-09-13 | ||
| 2011-03-31 | $20.00K 10-Q · filed 2012-05-21 | $31.00K derived: sum of 2 quarters · filed 2012-05-21 | $31.00K derived: sum of 3 quarters · filed 2012-05-21 | $31.00K derived: sum of 4 quarters · filed 2012-05-21 | ||
| 2010-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $11.00K derived: sum of 2 quarters · filed 2012-04-16 | $11.00K derived: sum of 3 quarters · filed 2012-04-16 | $11.00K 10-K · filed 2012-04-16 | ||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-21 | $0.00 derived: sum of 2 quarters · filed 2011-11-21 | $0.00 10-Q · filed 2011-11-21 | |||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-12 | $0.00 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |